Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma (Q38433490)

3 September 2017

title

Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma (English)

1 reference

3 September 2017

1 reference

1 reference

5

David Sidransky

1 reference

3 September 2017

Sokbom Kang

1

1 reference

3 September 2017

Hy-Sook Kim

2

1 reference

3 September 2017

Sang Soo Seo

3

1 reference

3 September 2017

Sang-Yoon Park

4

1 reference

3 September 2017

Seung Myung Dong

6

1 reference

3 September 2017

language of work or name

English

0 references

publication date

13 March 2007

1 reference

3 September 2017

1 reference

3 September 2017

volume

105

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

662-666

1 reference

The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

RAF/RAS oncogenes and mismatch-repair status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Elucidation of binding determinants and functional consequences of Ras/Raf-cysteine-rich domain interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

K-ras mutations and RASSF1A promoter methylation in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Mutations of the BRAF gene in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Detecting colorectal cancer in stool with the use of multiple genetic targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Molecular characterization of adenocarcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Analysis and clinical implications of K-ras gene mutations and infection with human papillomavirus types 16 and 18 in primary adenocarcinoma of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-Ras

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.01.045

10.1016/J.YGYNO.2007.01.045

7 January 2021

Identifiers

DOI

1 reference

3 September 2017

1 reference